Study S003359

A Open-Label, Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin in Healthy Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07362030
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 32
Start: 2025-04-14
Primary completion: 2025-12-27
Lead sponsor: Guangdong Raynovent Biotech Co., Ltd
Conditions: Obesity
Interventions: DRUG:RAY1225; DRUG:atorvastatin calcium tablet; DRUG:Metformin Tablets; DRUG:Warfarin Sodium Tablets; DRUG:Digoxin Tablets
Results posted: FALSE

Registered primary outcomes

Pharmacokinetic - Cmax [Day 1~Day 5 and Day 86~Day 107]
Pharmacokinetic -Area under the curve（AUC） [Day 1~Day 5 and Day 86~Day 107]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.